Posted by Michael Wonder on 29 Nov 2023
Patients on edge as drug price bargaining for Braftovi prolongs
28 November 2023 - Health insurance coverage for the colon cancer drug Braftovi (encorafenib) is unlikely to be available this year.
The National Health Insurance Service and Ono Pharmaceutical recently decided to extend the drug price negotiations for Braftovi after failing to reach a deal by the deadline.
